1. Differential development of large-cell neuroendocrine or small-cell lung carcinoma upon inactivation of 4 tumor suppressor genes.
- Author
-
Lázaro S, Pérez-Crespo M, Lorz C, Bernardini A, Oteo M, Enguita AB, Romero E, Hernández P, Tomás L, Morcillo MÁ, Paramio JM, and Santos M
- Subjects
- Animals, Carcinoma, Small Cell diagnostic imaging, Carcinoma, Small Cell pathology, Humans, Lung Neoplasms diagnostic imaging, Lung Neoplasms pathology, Mice, Neuroendocrine Tumors diagnostic imaging, Neuroendocrine Tumors pathology, Octreotide analogs & derivatives, Organometallic Compounds, PTEN Phosphohydrolase genetics, PTEN Phosphohydrolase metabolism, Positron-Emission Tomography, Radiopharmaceuticals, Retinoblastoma Binding Proteins genetics, Retinoblastoma Binding Proteins metabolism, Retinoblastoma-Like Protein p107 genetics, Retinoblastoma-Like Protein p107 metabolism, Transcriptome, Tumor Suppressor Protein p53 genetics, Tumor Suppressor Protein p53 metabolism, Carcinoma, Small Cell genetics, Genes, Tumor Suppressor, Lung Neoplasms genetics, Neuroendocrine Tumors genetics
- Abstract
High-grade neuroendocrine lung malignancies (large-cell neuroendocrine cell carcinoma, LCNEC, and small-cell lung carcinoma, SCLC) are among the most deadly lung cancer conditions with no optimal clinical management. The biological relationships between SCLC and LCNEC are still largely unknown and a current matter of debate as growing molecular data reveal high heterogeneity with potential therapeutic consequences. Here we describe murine models of high-grade neuroendocrine lung carcinomas generated by the loss of 4 tumor suppressors. In an Rbl1 -null background, deletion of Rb1 , Pten , and Trp53 floxed alleles after Ad-CMVcre infection in a wide variety of lung epithelial cells produces LCNEC. Meanwhile, inactivation of these genes using Ad-K5cre in basal cells leads to the development of SCLC, thus differentially influencing the lung cancer type developed. So far, a defined model of LCNEC has not been reported. Molecular and transcriptomic analyses of both models revealed strong similarities to their human counterparts. In addition, a
68 Ga-DOTATOC-based molecular-imaging method provides a tool for detection and monitoring the progression of the cancer. These data offer insight into the biology of SCLC and LCNEC, providing a useful framework for development of compounds and preclinical investigations in accurate immunocompetent models., Competing Interests: The authors declare no competing interest., (Copyright © 2019 the Author(s). Published by PNAS.)- Published
- 2019
- Full Text
- View/download PDF